Azenta, Inc. (AZTA) SEC Filings & Earnings Calls

Execution risk: actual charges, timing, and savings may differ from estimates.

“Actual charges, timing and savings may differ from these estimates due to changes in the scope or timing of the actions, negotiations with landlords, applicable legal requirements and other implementation matters.” · word for word

Potential leadership transition or consulting arrangement; lack of detail increases uncertainty.

“Letter agreement with Dr. Martin D. Madaus; no terms disclosed.”

Credit exposure from vendor loan now eliminated.

“the credit exposure associated with the transaction has been retired” · word for word

Leadership vacuum and potential strategic drift during CEO search; one-time charge reduces near-term profitability.

“CEO resignation effective immediately; interim CEO appointed; search for permanent CEO underway.”

B Medical Systems sale completion risk

“On July 1, 2026, the Company completed the sale of the B Medical Systems business to Thelema for $63.0 million.” · word for word

Goodwill impairment risk

“Impairment of goodwill and intangible assets 149,083 for nine months ended June 30, 2026.” · word for word

Litigation liability from Edwards Vacuum

“The Supreme Court of the State of New York granted the Company's motion to dismiss Edwards Vacuum LLC's lawsuit in its entirety.” · word for word

Margin pressure from fixed-cost absorption and quality remediation costs in Automated Stores.

“Gross margin decrease of 130bps driven by unfavorable fixed-cost absorption and costs related to quality remediation and rework activities in Automated Stores.”

Q4 organic revenue guidance of low single digit decline indicates near-term demand weakness.

“Total organic revenue... expected to decline approximately in the low single digits relative to the fourth quarter of fiscal 2025.” · word for word

Free cash flow negative $5M in Q3, though balance sheet strong with $529M cash.

“free cash flow... was negative $5 million.” · word for word

Vendor loan of $35M to buyer introduces counterparty credit risk; buyer previously failed to secure financing.

“Vendor loan of $35M to Thelema; buyer previously unable to secure financing by March 31, 2026.”

Related-party transaction with Luc Provost, VP and CEO of B Medical, creates governance risk.

“Thelema majority owned by Luc Provost, a VP of Azenta and CEO of B Medical.”

B Medical Systems sale completion risk

“On March 27, 2026, the Company was informed by Thelema that it had not yet secured the financing required to complete the transaction and, solely as a result of the non‑satisfaction of that financing condition, the transaction did not close by March 31, 2026.” · word for word

Goodwill impairment risk

“Impairment of goodwill and intangible assets 149,083 for three months ended March 31, 2026.” · word for word

Litigation liability from Edwards Vacuum

“The Company's motion to dismiss Edwards Vacuum LLC's lawsuit filed on September 12, 2025 remains pending.” · word for word

Goodwill impairment of $149M signals potential overpayment for acquisitions or deteriorating business outlook

“Non-cash goodwill impairment charge of $149 million” · word for word

Significant guidance reduction across revenue and margin

“FY'26 organic revenue guidance cut from 3-5% growth to -2% to +1%; EBITDA margin expansion cut from +300bps to -125bps to flat”

Execution gaps and cautious demand environment in North America

“Results fell short of expectations, reflecting both execution gaps and a more cautious demand environment, particularly in North America”

Key business unit leadership transition could cause short-term disruption.

“Departure of President of Multiomics business; new appointee starts immediately.”

Transaction may not close; Azenta retains B Medical Systems with uncertain path forward.

“There can be no assurance that the Transaction will be completed on a revised timeline or at all” · word for word

Integration risk; contingent consideration tied to milestone achievement.

“up to GBP 1.8 million in contingent consideration upon the completion of certain milestones.” · word for word

Discontinued operations loss

“Loss from discontinued operations, net of tax $ (10,242)” · word for word

B Medical Systems sale completion risk

“Thelema’s securing of final residual financing for the remaining acquisition payment of $54.0 million is a condition precedent to completion of the sale, and there can be no assurance that this condition will be satisfied or that the sale will be completed.” · word for word

Gross margin pressure from lost cost leverage and rework costs; turnaround not linear.

“Gross margin was 42.9%, down 380 basis points...driven by lost cost leverage...and costs related to rework on several Automated Stores projects.” · word for word

Revenue decline in core products (Automated Stores, Cryogenic Systems).

“lower revenues in Core Products, particularly in Automated Stores and Cryogenic Systems” · word for word

Loss of board member with compensation committee experience may reduce governance depth.

“Resignation of Alan P. Malus from Board and HR/Compensation Committee.”

Financing condition precedent may prevent completion of sale; break-up fee provides partial downside protection.

“Thelema’s securing of final residual financing for the acquisition is a condition precedent to completion ... there can be no assurance that this condition will be satisfied or that the transaction will be completed.” · word for word

Related-party transaction with Luc Provost, VP of Azenta and CEO of B Medical, as majority owner of Thelema, introduces potential conflict of interest.

“The transaction is with a related party, as Luc Provost, the current Vice President of Azenta and CEO of B Medical, is Thelema’s majority owner.” · word for word

Material weakness in internal control over financial reporting

“we identified a material weakness in our internal control over financial reporting, as we did not design and maintain effective controls over the classification of certain costs in the Consolidated Statement of Operations.” · word for word

Clawback of executive compensation

“The aggregate amount of erroneously awarded compensation that remained outstanding at the end of FY2025 was $56,116.” · word for word

FY2023-2025 LTIP zero payout

“resulting in all three financial metrics falling below the threshold and 0% of target earned.” · word for word

Repurchase program does not obligate company to buy any specific amount; execution depends on market conditions and liquidity.

“Repurchase Program does not obligate the Company to acquire any particular amount of common stock.” · word for word

Internal control material weaknesses

“We identified a material weakness in our internal control over financial reporting as of September 30, 2024, as we did not design and maintain effective controls related to the review of the cash flow statement.” · word for word

Goodwill impairment risk

“During the third quarter of fiscal year 2025, we determined that a sustained decline in our stock price was an indicator of potential impairment and performed an interim quantitative goodwill impairment test for our reporting units as of June 30, 2025.” · word for word

China geopolitical risk

“the loss of revenues and potential adverse impact on our relationships in China or with Chinese customers as a result of adverse developments in trade policies and resulting trade tensions between the United States and China” · word for word

Multiomics segment faces cost and volume pressures in parts, partially offset by favorable mix.

“Adjusted gross margin down 20bps YoY due to higher costs and lower volumes in parts of Multiomics”